Contact

News

Testimonials, success stories, grants and more...

At OBBI, we focus on enabling groundbreaking advancements on organoids, to drive innovation in research, diagnostics, and therapeutic development.

Visuel pour international Biotherapy Days

Biotherapy Days 2026

Dr. Danièle Noël, Research Director at IRMB, will be speaking at Biotherapy Days 2026 in Toulouse—the premier gathering for the biotherapy and bioproduction community in Occitanie. As part of her talk, she will present the OBBI initiative, offering valuable visibility...

Biofit 2025 – Strasbourg

OBBI joins BioFIT 2025 to connect with partners in biotech, pharma, and translational research. With our dual expertise in organoid and EV bioproduction, we offer scalable, standardized solutions for early-stage innovation. Let’s shape the future of biotherapies—together....

SFNano 2025 – Lyon

OBBI Showcases EV and Organoid Platforms at SFNano 2025...
Logo Innovative Thérapies Days 2025

INNOVATIVE Therapies Days 2025

OBBI will be present at Innovative Therapies Days, a key event dedicated to cutting-edge advances in biotherapies and regenerative medicine. We look forward to sharing our expertise and connecting with industry and academic leaders....

10th Bioproduction Congress in Lyon

Montserrat Bosch Grau, Chief Business Officer at OBBI, will attend the 10th Bioproduction Congress in Lyon—the leading European event for biomanufacturing. This will be an opportunity to present OBBI’s expertise in organoid and extracellular vesicle bioproduction and to connect with...

Réseau des Intégrateurs Biothérapie–Bioproduction

OBBI is an active member of the Réseau des Intégrateurs Biothérapie–Bioproduction, a national network of platforms labeled under France 2030. This network fosters collaboration between integrators across France, aiming to accelerate the development and industrialization of advanced biotherapies....

Pôle Universitaire d’Innovation (PUI) Université de Montpellier

OBBI receives support from the University of Montpellier’s Innovation Hub (PUI) through the IN-Lab Engineering program. This initiative strengthens strategic development within academic platforms, enhancing OBBI’s ability to advance projects, build industrial partnerships, and promote organoid and extracellular vesicle technologies....

CeBBOc

OBBI is supported by CeBBOc, a regional initiative dedicated to strengthening the biotherapies sector in Occitanie. Through the co-funding of OBBI’s Business Development role, CeBBOc helps drive partnerships and the transfer of organoid and extracellular vesicle technologies to industry and...

France 2030

OBBI is supported by France 2030, the national investment program accelerating innovation in strategic sectors such as health and biotherapies. As a designated Biotherapy–Bioproduction Integrator, OBBI leverages this support to expand its organoid and extracellular vesicle production capacities, invest in...
Logo AFSSI Connexions

AFSSI Connexions

OBBI will take part in the upcoming AFSSI Connexions, the annual event for France’s innovative health technology sector. We look forward to showcasing our expertise in the bioproduction of organoids and extracellular vesicles, and to engaging with academic, industrial, and...
OBBI Integrator
Résumé de la politique de confidentialité

Ce site utilise des cookies afin que nous puissions vous fournir la meilleure expérience utilisateur possible. Les informations sur les cookies sont stockées dans votre navigateur et remplissent des fonctions telles que vous reconnaître lorsque vous revenez sur notre site Web et aider notre équipe à comprendre les sections du site que vous trouvez les plus intéressantes et utiles.